Pathophysiology: is PSVD an immune, a vascular or a coagulation disorder? - Paris PSVD Meeting

Pathophysiology: is PSVD an immune, a vascular or a coagulation disorder? - Paris PSVD Meeting

🎙 Marco Senzolo 👥 2K 📅 January 23, 2026 ⏱ 24 min 👁 179 📄 expert opinion 🧭 2026-08-16
Available in: English (current) Français

Keywords

PSVDendothelial dysfunctioncoagulationimmune systempathophysiology

Summary

In this presentation from the Paris PSVD Meeting 2025, Marco Senzolo discusses the pathophysiology of Porto-Sinusoidal Vascular Disease (PSVD), addressing whether it is primarily an immune, vascular, or coagulation disorder. He proposes a unifying model of chronic endothelial injury driven by multiple hits, including drug toxicity (azathioprine, oxaliplatin), arsenic exposure, bacterial translocation, and immune-mediated damage. He highlights the role of anti-endothelial cell antibodies, systemic inflammation, and the TGF-beta pathway in promoting endothelial-to-mesenchymal transition and fibrosis. He also examines the contribution of prothrombotic states such as antiphospholipid syndrome and myeloproliferative neoplasms, which induce endothelial activation and a procoagulant phenotype. The presentation integrates evidence from liver biopsies, extracellular vesicle analysis, and genetic network studies to support the concept of a shared final pathway of vascular dysfunction. Senzolo concludes that PSVD is a multifactorial disease with endothelial dysfunction as a central feature, and he emphasizes the need for further research to clarify the interplay between immune, vascular, and coagulation mechanisms.

157 words

Critical Evaluation

Value of the Information & Strength of the Argument

The presentation provides a comprehensive and nuanced overview of the current understanding of PSVD pathophysiology. It synthesizes a wide range of evidence, including drug-induced endothelial damage, immune-mediated mechanisms, and prothrombotic states, and proposes a unifying model of chronic endothelial injury. The argumentation is logical and well-structured, moving from specific triggers to common downstream pathways. The speaker acknowledges the speculative nature of some aspects and highlights areas requiring further investigation, which adds to the credibility. The value lies in its integrative approach, offering a framework for understanding the disease that could inform future research and therapeutic strategies.

Scientific Rigor, Source Quality, Title Accuracy

The presentation demonstrates scientific rigor by referencing specific studies and mechanisms, such as the role of glutathione depletion in drug-induced endothelial damage, the association with anti-endothelial cell antibodies, and the involvement of the TGF-beta pathway. However, as a conference talk, it lacks detailed citations and peer-reviewed verification. The title accurately reflects the content, which focuses on the pathophysiological debate. The description mentions the meeting and organizers, but no specific sources are listed. The talk is aimed at healthcare professionals, but this does not detract from its scientific merit.

199 words

Title / Content Match

The title accurately reflects the content, which discusses the pathophysiological mechanisms of PSVD, focusing on immune, vascular, and coagulation aspects.

Quality & Reliability

8/10

Presentation by an expert in hepatology, based on a synthesis of current research and clinical experience, with references to specific mechanisms and studies. However, it is a conference talk and not a peer-reviewed publication, and some statements are speculative.

Key Moments

Contribution & Novelties

This presentation offers an integrative model of PSVD pathophysiology, emphasizing endothelial dysfunction as a central hub connecting immune, vascular, and coagulation mechanisms. It synthesizes diverse evidence and highlights the role of extracellular vesicles as potential biomarkers. The talk also underscores the importance of considering associated conditions and the need for larger studies.

Pour aller plus loin :

  • Porto-sinusoidal vascular disease — Overview of PSVD, its clinical features, and diagnosis.
  • Endothelial dysfunction — General concept of endothelial dysfunction and its role in vascular diseases.
  • TGF beta signaling pathway — Details on the TGF-beta pathway, which is central to the fibrosis mechanisms discussed.
  • Antiphospholipid syndrome — Information on antiphospholipid syndrome, a prothrombotic condition associated with PSVD.
  • Myeloproliferative neoplasm — Overview of myeloproliferative neoplasms and their vascular complications.

125 words

Radar Profile

The radar profile shows high scores across all dimensions, indicating a technically detailed and reliable presentation. The balance between quantity and quality of information is strong, with a high level of technical depth appropriate for a specialized audience.

Reliability 8/10